Francesca Morgante, Miryam Carecchio, Chiara Reale, Federica Invernizzi, Valentina Monti, Simona Petrucci, Monia Ginevrino, Giovanna Zorzi, Federica Zibordi, Anna Rita Bentivoglio, Enza Maria Valente, Nardo Nardocci, Barbara Garavaglia
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2017;21(2):269-271
PMID: 27771228
BACKGROUND
Mutations in HPCA, a gene implicated in calcium signaling in the striatum, have been recently described in recessive dystonia cases previously grouped under the term "DYT2 dystonia". Positive patients reported so far show focal onset during childhood with subsequent generalization and a slowly progressive course to adulthood.
METHODS
73 patients with isolated dystonia of various distribution, manifesting within 21 years of age, were enrolled in this Italian study and underwent a mutational screening of HPCA gene by means of Sanger sequencing.
RESULTS/CONCLUSIONS
Mean age at onset was 10.2 (±5.1) years and mean age at the time of genetic testing was 33 (±14.2) years. Mean disease duration at the time of enrollment was 22.7 (±12.8) years. None of the patients enrolled was found to carry HPCA mutations, rising suspicion that these probably represent a very rare cause of dystonia in childhood-adolescence. Larger studies will help determining the real mutational frequency of this gene also in different ethnic groups.
Copyright © 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.